These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26780565)

  • 1. Two short-acting kappa opioid receptor antagonists (zyklophin and LY2444296) exhibited different behavioral effects from the long-acting antagonist norbinaltorphimine in mouse anxiety tests.
    Huang P; Yakovleva T; Aldrich JV; Tunis J; Parry C; Liu-Chen LY
    Neurosci Lett; 2016 Feb; 615():15-20. PubMed ID: 26780565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zyklophin, a short-acting kappa opioid antagonist, induces scratching in mice.
    Dimattio KM; Yakovleva TV; Aldrich JV; Cowan A; Liu-Chen LY
    Neurosci Lett; 2014 Mar; 563():155-9. PubMed ID: 24503508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species differences in the effects of the κ-opioid receptor antagonist zyklophin.
    Sirohi S; Aldrich JV; Walker BM
    Alcohol; 2016 Mar; 51():43-9. PubMed ID: 26992699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Effects of the novel relatively short-acting kappa opioid receptor antagonist LY2444296 in behaviors observed after chronic extended-access cocaine self-administration in rats".
    Valenza M; Butelman ER; Kreek MJ
    Psychopharmacology (Berl); 2017 Aug; 234(15):2219-2231. PubMed ID: 28550455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic antidepressant-like effects between a kappa opioid antagonist (LY2444296) and a delta opioid agonist (ADL5859) in the mouse forced swim test.
    Huang P; Tunis J; Parry C; Tallarida R; Liu-Chen LY
    Eur J Pharmacol; 2016 Jun; 781():53-9. PubMed ID: 27044434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a post-shock injection of the kappa opioid receptor antagonist norbinaltorphimine (norBNI) on fear and anxiety in rats.
    Rogala B; Li Y; Li S; Chen X; Kirouac GJ
    PLoS One; 2012; 7(11):e49669. PubMed ID: 23166745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats.
    Knoll AT; Meloni EG; Thomas JB; Carroll FI; Carlezon WA
    J Pharmacol Exp Ther; 2007 Dec; 323(3):838-45. PubMed ID: 17823306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Big dynorphin, a prodynorphin-derived peptide produces NMDA receptor-mediated effects on memory, anxiolytic-like and locomotor behavior in mice.
    Kuzmin A; Madjid N; Terenius L; Ogren SO; Bakalkin G
    Neuropsychopharmacology; 2006 Sep; 31(9):1928-37. PubMed ID: 16292317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infralimbic kappa opioid and muscarinic M1 receptor interactions in the concurrent modulation of anxiety and memory.
    Wall PM; Messier C
    Psychopharmacology (Berl); 2002 Mar; 160(3):233-44. PubMed ID: 11889492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zyklophin, a systemically active selective kappa opioid receptor peptide antagonist with short duration of action.
    Aldrich JV; Patkar KA; McLaughlin JP
    Proc Natl Acad Sci U S A; 2009 Oct; 106(43):18396-401. PubMed ID: 19841255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anxiolytic- and antidepressant-like effects of ATPM-ET, a novel κ agonist and μ partial agonist, in mice.
    Wang Q; Long Y; Hang A; Zan GY; Shu XH; Wang YJ; Liu JG
    Psychopharmacology (Berl); 2016 Jun; 233(12):2411-8. PubMed ID: 27113225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of short-acting κ-opioid receptor antagonists with anxiolytic-like activity.
    Peters MF; Zacco A; Gordon J; Maciag CM; Litwin LC; Thompson C; Schroeder P; Sygowski LA; Piser TM; Brugel TA
    Eur J Pharmacol; 2011 Jul; 661(1-3):27-34. PubMed ID: 21539838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enkephalin analog, cyclo[N(ε),N(β)-carbonyl-D-Lys(2),Dap(5)] enkephalinamide (cUENK6), inhibits the ethanol withdrawal-induced anxiety-like behavior in rats.
    Gibula-Bruzda E; Marszalek-Grabska M; Witkowska E; Izdebski J; Kotlinska JH
    Alcohol; 2015 May; 49(3):229-36. PubMed ID: 25716198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol.
    Berrendero F; Maldonado R
    Psychopharmacology (Berl); 2002 Aug; 163(1):111-7. PubMed ID: 12185408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRF1-R activation of the dynorphin/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior.
    Bruchas MR; Land BB; Lemos JC; Chavkin C
    PLoS One; 2009 Dec; 4(12):e8528. PubMed ID: 20052275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiolytic-like effects of alverine citrate in experimental mouse models of anxiety.
    Gupta D; Radhakrishnan M; Kurhe Y
    Eur J Pharmacol; 2014 Nov; 742():94-101. PubMed ID: 25199966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of buprenorphine on behavioral tests for antidepressant and anxiolytic drugs in mice.
    Falcon E; Maier K; Robinson SA; Hill-Smith TE; Lucki I
    Psychopharmacology (Berl); 2015 Mar; 232(5):907-15. PubMed ID: 25178815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a hydroethanolic extract of Boophone disticha bulb on anxiety-related behaviour in naive BALB/c mice.
    Pote W; Musarira S; Chuma D; Gadaga LL; Mwandiringana E; Tagwireyi D
    J Ethnopharmacol; 2018 Mar; 214():218-224. PubMed ID: 29223391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of central blockade of kappa-opioid receptors on neuropeptide Y-induced feeding in the rat.
    Lambert PD; Wilding JP; al-Dokhayel AA; Gilbey SG; Bloom SR
    Brain Res; 1993 Nov; 629(1):146-8. PubMed ID: 7904531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The gerbil elevated plus-maze II: anxiolytic-like effects of selective neurokinin NK1 receptor antagonists.
    Varty GB; Cohen-Williams ME; Morgan CA; Pylak U; Duffy RA; Lachowicz JE; Carey GJ; Coffin VL
    Neuropsychopharmacology; 2002 Sep; 27(3):371-9. PubMed ID: 12225694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.